State Street SPDR S&P Biotech ETF (XBI) is a publicly traded company in the Financial Services sector, operating within the Asset Management industry. The company is headquartered in Boston, MA, United States.
XBI has IPO date of 2006-02-06, listed on the NYSE, a market capitalization of $7.69B.
State Street SPDR S&P Biotech ETF (XBI) is an exchange-traded fund designed to track the performance of the S&P Biotechnology Select Industry Index. The fund invests at least 80% of its total assets in securities that comprise the index, using a sampling strategy to replicate index performance. XBI provides exposure to the biotechnology segment of the S&P Total Market Index, offering investors a diversified way to gain access to the U.S. biotech industry.
